AMLX - Wall Street Estimates - Amylyx Pharmaceuticals, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 3.575

1.85 %

$ 306 M

Market Cap

-0.94

P/E

Price Target Average

64.34%

Revenue Forecast Estimate

--57.55%

EBIT Estimate

--16.61%

Net Income Estimate

--35.31%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Amylyx Pharmaceuticals, Inc.

Wall Street analysts predict an average 1-year price target for AMLX of $5.88 , with forecasts ranging from a low of $3 to a high of $11 .

AMLX Lowest Price Target Wall Street Target

3 USD -16.08%

AMLX Average Price Target Wall Street Target

5.88 USD 64.34%

AMLX Highest Price Target Wall Street Target

11 USD 207.69%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free